Literature DB >> 1310195

Sequence analysis of the spike protein gene of murine coronavirus variants: study of genetic sites affecting neuropathogenicity.

F I Wang1, J O Fleming, M M Lai.   

Abstract

Mouse hepatitis virus (MHV), a coronavirus, causes encephalitis and demyelination in susceptible rodents. Previous investigations have shown that the MHV spike (S) protein is a critical determinant of viral tropism and pathogenicity in mice and rats. To understand the molecular basis of MHV neuropathogenesis, we studied the spike protein gene sequences of several neutralization-resistant variants of the JHM strain of MHV, which were selected with monoclonal antibodies (MAbs) specific for the S protein. We found that variant 2.2-V-1, which was selected with MAb J.2.2 and primarily caused demyelination, had a single point mutation at nucleotide (NT) 3340, as compared to the parental JHM virus, which predominantly caused encephalitis. This site was in the S2 subunit of the S protein. In contrast, variant 7.2-V-1, which was selected with MAb J.7.2 and primarily caused encephalitis, had two point mutations at NT 1766 and 1950, which were in the S1 subunit. Finally, the double mutant 2.2/7.2-V-2, which was selected with both MAbs J.2.2 and J.7.2, and was attenuated with respect to both virulence and the ability to cause demyelination, had a deletion spanning from NT 1523 to 1624 in the S1 and a point mutation at NT 3340 in the S2. We conclude that at least two regions of the S protein contribute to neuropathogenicity of MHV. We have also isolated a partial revertant of 2.2-V-1, which was partially resistant to MAb J.2.2 but retained the same neuropathogenicity as the variant 2.2-V-1. This revertant retained the mutation at NT 3340, but had a second-site mutation at NT 1994, further confirming that NT 3340 contributed to the pathogenic phenotype of MHV. By comparing these results with MHV variants isolated in other laboratories, which had mutations in other sites on the S gene and yet retained the demyelinating ability, we suggest that the ability of JHM viruses to induce demyelination is determined by the interaction of multiple sites on the S gene, rather than the characteristics of a single, unique site. Our study also revealed the possible presence of microheterogeneity of S gene sequence, particularly in the S1 region, in these viruses. The sequence microheterogeneity may also contribute to the differences in their biological properties.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310195      PMCID: PMC7131202          DOI: 10.1016/0042-6822(92)90041-m

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  38 in total

1.  Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein.

Authors:  T M Gallagher; S E Parker; M J Buchmeier
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

2.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

3.  The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis.

Authors:  H Wege; J Winter; R Meyermann
Journal:  J Gen Virol       Date:  1988-01       Impact factor: 3.891

4.  Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments.

Authors:  L S Sturman; C S Ricard; K V Holmes
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

5.  Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus.

Authors:  J O Fleming; S A Stohlman; R C Harmon; M M Lai; J A Frelinger; L P Weiner
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

6.  Enhancement of plaque formation and cell fusion of an enteropathogenic coronavirus by trypsin treatment.

Authors:  J Storz; R Rott; G Kaluza
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

7.  Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59.

Authors:  C J Pachuk; P J Bredenbeek; P W Zoltick; W J Spaan; S R Weiss
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

8.  Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease.

Authors:  J O Fleming; M D Trousdale; J Bradbury; S A Stohlman; L P Weiner
Journal:  Microb Pathog       Date:  1987-07       Impact factor: 3.738

9.  Localization of extensive deletions in the structural genes of two neurotropic variants of murine coronavirus JHM.

Authors:  N La Monica; L R Banner; V L Morris; M M Lai
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

10.  Characterization of small plaque mutants of mouse hepatitis virus, JHM strain.

Authors:  S Makino; F Taguchi; M Hayami; K Fujiwara
Journal:  Microbiol Immunol       Date:  1983       Impact factor: 1.955

View more
  33 in total

1.  Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure.

Authors:  C L Rowe; J O Fleming; M J Nathan; J Y Sgro; A C Palmenberg; S C Baker
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Cytotoxic T-cell-resistant variants arise at early times after infection in C57BL/6 but not in SCID mice infected with a neurotropic coronavirus.

Authors:  L Pewe; S Xue; S Perlman
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure.

Authors:  C Daniel; R Anderson; M J Buchmeier; J O Fleming; W J Spaan; H Wege; P J Talbot
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

4.  Intracellular complexes of viral spike and cellular receptor accumulate during cytopathic murine coronavirus infections.

Authors:  P V Rao; T M Gallagher
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

5.  A single amino acid change within antigenic domain II of the spike protein of bovine coronavirus confers resistance to virus neutralization.

Authors:  D Yoo; D Deregt
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

6.  Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants.

Authors:  K Saeki; N Ohtsuka; F Taguchi
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain.

Authors:  S A Stohlman; S Kyuwa; J M Polo; D Brady; M M Lai; C C Bergmann
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 8.  Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.

Authors:  Susan R Weiss; Sonia Navas-Martin
Journal:  Microbiol Mol Biol Rev       Date:  2005-12       Impact factor: 11.056

9.  A severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine coronavirus.

Authors:  Lecia Pewe; Haixia Zhou; Jason Netland; Chandra Tangudu; Heidi Olivares; Lei Shi; Dwight Look; Thomas Gallagher; Stanley Perlman
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 10.  Coronavirus spike proteins in viral entry and pathogenesis.

Authors:  T M Gallagher; M J Buchmeier
Journal:  Virology       Date:  2001-01-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.